Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Madrigal Pharmaceuticals Cash on Hand 2010-2025 | MDGL

Madrigal Pharmaceuticals cash on hand from 2010 to 2025. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
  • Madrigal Pharmaceuticals cash on hand for the quarter ending March 31, 2025 was $0.848B, a 19.92% decline year-over-year.
  • Madrigal Pharmaceuticals cash on hand for 2024 was $0.931B, a 46.85% increase from 2023.
  • Madrigal Pharmaceuticals cash on hand for 2023 was $0.634B, a 76.75% increase from 2022.
  • Madrigal Pharmaceuticals cash on hand for 2022 was $0.359B, a 32.71% increase from 2021.
  
Madrigal Pharmaceuticals Annual Cash on Hand
(Millions of US $)
2024 $931
2023 $634
2022 $359
2021 $270
2020 $284
2019 $439
2018 $484
2017 $192
2016 $41
2015 $0
2014 $98
2013 $91
2012 $101
2011 $40
2010 $51
2009 $44
Madrigal Pharmaceuticals Quarterly Cash on Hand
(Millions of US $)
2025-03-31 $848
2024-12-31 $931
2024-09-30 $1,004
2024-06-30 $1,063
2024-03-31 $1,059
2023-12-31 $634
2023-09-30 $232
2023-06-30 $298
2023-03-31 $329
2022-12-31 $359
2022-09-30 $153
2022-06-30 $212
2022-03-31 $220
2021-12-31 $270
2021-09-30 $299
2021-06-30 $324
2021-03-31 $307
2020-12-31 $284
2020-09-30 $336
2020-06-30 $384
2020-03-31 $409
2019-12-31 $439
2019-09-30 $454
2019-06-30 $466
2019-03-31 $478
2018-12-31 $484
2018-09-30 $489
2018-06-30 $490
2018-03-31 $183
2017-12-31 $192
2017-09-30 $62
2017-06-30 $67
2017-03-31 $40
2016-12-31 $41
2016-09-30 $40
2016-06-30 $43
2016-03-31 $52
2015-12-31 $0
2015-09-30 $88
2015-06-30 $98
2015-03-31 $77
2014-12-31 $98
2014-09-30 $119
2014-06-30 $112
2014-03-31 $79
2013-12-31 $91
2013-09-30 $53
2013-06-30 $70
2013-03-31 $90
2012-12-31 $101
2012-09-30 $55
2012-06-30 $45
2012-03-31 $57
2011-12-31 $40
2011-09-30 $51
2011-06-30 $63
2011-03-31 $40
2010-12-31 $51
2010-09-30 $54
2010-06-30 $49
2010-03-31 $58
2009-12-31 $44
2009-09-30 $52
2009-06-30 $61
2009-03-31 $85
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $6.460B $0.180B
Madrigal Pharmaceuticals, Inc. is engaged in developing small-molecule drugs addressing cardiovascular and metabolic diseases. Its products pipeline include MGL-3196, an orally administered liver-directed thyroid hormone receptor-? agonist that is used for the treatment of NASH, dyslipidemia/hypercholesterolemia and high triglycerides; and MGL-3745, a thyroid hormone receptor-? agonist which are in pre-clinical trial stage. Madrigal Pharmaceuticals Inc., formerly known as Synta Pharmaceuticals Corp., is based in Fort Washington, Pennsylvania.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $85.040B 31.90
Zoetis (ZTS) United States $72.587B 27.08
Daiichi Sankyo, - (DSNKY) Japan $46.334B 23.57
Takeda Pharmaceutical (TAK) Japan $44.897B 8.93
Sandoz Group AG (SDZNY) Switzerland $20.596B 0.00
Summit Therapeutics (SMMT) United States $17.727B 0.00
Merck (MKKGY) Germany $16.659B 12.21
United Therapeutics (UTHR) United States $13.773B 12.19
Shionogi (SGIOY) Japan $12.948B 0.00
Neurocrine Biosciences (NBIX) United States $11.977B 41.02
IPSEN (IPSEY) France $9.572B 0.00
Orion OYJ (ORINY) Finland $8.798B 23.79
Corcept Therapeutics (CORT) United States $7.962B 64.72
Stevanato Group S.p.A (STVN) Italy $7.274B 44.48
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.976B 0.00
Ionis Pharmaceuticals (IONS) United States $5.341B 0.00
Grifols, S.A (GRFS) Spain $5.335B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.040B 15.33
Soleno Therapeutics (SLNO) United States $3.780B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.973B 10.41
Crinetics Pharmaceuticals (CRNX) United States $2.925B 0.00
Hypermarcas (HYPMY) Brazil $2.692B 17.71
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.382B 12.88
BioCryst Pharmaceuticals (BCRX) United States $2.143B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $2.073B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.854B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.671B 0.00
Indivior (INDV) United States $1.564B 6.63
Guardian Pharmacy Services (GRDN) United States $1.563B 0.00
Evotec AG (EVO) Germany $1.442B 0.00
Dyne Therapeutics (DYN) United States $1.345B 0.00
ARS Pharmaceuticals (SPRY) United States $1.336B 0.00
Ocular Therapeutix (OCUL) United States $1.150B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.107B 22.14
Harrow (HROW) United States $1.042B 0.00
Collegium Pharmaceutical (COLL) United States $0.971B 5.24
Ardelyx (ARDX) United States $0.928B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.872B 0.00
Enliven Therapeutics (ELVN) United States $0.827B 0.00
Cronos Group (CRON) Canada $0.825B 0.00
Xeris Biopharma Holdings (XERS) United States $0.763B 0.00
Akebia Therapeutics (AKBA) United States $0.685B 0.00
AleAnna (ANNA) United States $0.666B 0.00
KalVista Pharmaceuticals (KALV) United States $0.593B 0.00
Elite Pharmaceuticals (ELTP) United States $0.578B 0.00
Xencor (XNCR) United States $0.574B 0.00
USANA Health Sciences (USNA) United States $0.564B 12.26
Bioventus (BVS) United States $0.558B 14.15
Regulus Therapeutics (RGLS) United States $0.545B 0.00
Savara (SVRA) United States $0.531B 0.00
CytoDyn (CYDY) United States $0.486B 0.00
Relay Therapeutics (RLAY) United States $0.482B 0.00
Zevra Therapeutics (ZVRA) United States $0.474B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.460B 0.00
Altimmune (ALT) United States $0.453B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.431B 0.00
Siga Technologies (SIGA) United States $0.428B 8.94
Tourmaline Bio (TRML) United States $0.425B 0.00
Verve Therapeutics (VERV) United States $0.413B 0.00
Organogenesis (ORGO) United States $0.391B 0.00
Oruka Therapeutics (ORKA) United States $0.377B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.355B 9.58
Heron Therapeutics (HRTX) United States $0.301B 0.00
Nature's Sunshine Products (NATR) United States $0.273B 25.20
Aquestive Therapeutics (AQST) United States $0.236B 0.00
ProKidney (PROK) United States $0.236B 0.00
MediWound (MDWD) Israel $0.221B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.205B 0.00
OmniAb (OABI) United States $0.193B 0.00
Nanobiotix S.A (NBTX) France $0.182B 0.00
Avita Medical (RCEL) United States $0.171B 0.00
Wellgistics Health (WGRX) United States $0.170B 0.00
Liminatus Pharma (LIMN) $0.168B 0.00
Journey Medical (DERM) United States $0.160B 0.00
4D Molecular Therapeutics (FDMT) United States $0.159B 0.00
Esperion Therapeutics (ESPR) United States $0.159B 0.00
Inhibikase Therapeutics (IKT) United States $0.149B 0.00
Korro Bio (KRRO) United States $0.142B 0.00
Aclaris Therapeutics (ACRS) United States $0.142B 0.00
Profound Medical (PROF) Canada $0.142B 0.00
Aldeyra Therapeutics (ALDX) United States $0.129B 0.00
Nektar Therapeutics (NKTR) United States $0.127B 0.00
Larimar Therapeutics (LRMR) United States $0.127B 0.00
Protara Therapeutics (TARA) United States $0.123B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.123B 0.00
Lyell Immunopharma (LYEL) United States $0.123B 0.00
Innate Pharma SA (IPHYF) France $0.122B 0.00
VAXART, INC (VXRT) United States $0.115B 0.00
Lexeo Therapeutics (LXEO) United States $0.108B 0.00
Achieve Life Sciences (ACHV) Canada $0.107B 0.00
Cassava Sciences (SAVA) United States $0.101B 0.00
OptiNose (OPTN) United States $0.098B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.092B 0.00
Cardiol Therapeutics (CRDL) Canada $0.092B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.090B 0.00
Champions Oncology (CSBR) United States $0.088B 14.43
Dominari Holdings (DOMH) United States $0.087B 0.00
Fractyl Health (GUTS) United States $0.083B 0.00
Galectin Therapeutics (GALT) United States $0.081B 0.00
Arch Biopartners (ACHFF) Canada $0.080B 0.00
Inotiv (NOTV) United States $0.078B 0.00
ESSA Pharma (EPIX) Canada $0.076B 0.00
Pyxis Oncology (PYXS) United States $0.075B 0.00
Telomir Pharmaceuticals (TELO) United States $0.074B 0.00
Unicycive Therapeutics (UNCY) United States $0.072B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.070B 52.33
Context Therapeutics (CNTX) United States $0.064B 0.00
Assertio Holdings (ASRT) United States $0.064B 0.00
Nutriband (NTRB) United States $0.063B 0.00
Metagenomi (MGX) United States $0.062B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.061B 0.00
Vivani Medical (VANI) United States $0.061B 0.00
Surrozen (SRZN) United States $0.061B 0.00
Gain Therapeutics (GANX) United States $0.059B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Prelude Therapeutics (PRLD) United States $0.050B 0.00
Century Therapeutics (IPSC) United States $0.048B 0.00
Karyopharm Therapeutics (KPTI) United States $0.046B 0.00
Mural Oncology (MURA) Ireland $0.046B 0.00
PMV Pharmaceuticals (PMVP) United States $0.045B 0.00
NRx Pharmaceuticals (NRXP) United States $0.042B 0.00
Avalo Therapeutics (AVTX) United States $0.042B 0.00
ElectroCore (ECOR) United States $0.040B 0.00
Iterum Therapeutics (ITRM) Ireland $0.039B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.038B 0.00
Acrivon Therapeutics (ACRV) United States $0.036B 0.00
Rafael Holdings (RFL) United States $0.036B 0.00
FibroGen (FGEN) United States $0.031B 0.00
SCYNEXIS (SCYX) United States $0.031B 0.00
PolyPid (PYPD) Israel $0.028B 0.00
Tempest Therapeutics (TPST) United States $0.025B 0.00
CASI Pharmaceuticals (CASI) China $0.024B 0.00
Enlivex Therapeutics (ENLV) Israel $0.024B 0.00
Lipocine (LPCN) United States $0.021B 0.00
Natural Alternatives (NAII) United States $0.020B 0.00
Mannatech (MTEX) United States $0.020B 0.00
DURECT (DRRX) United States $0.020B 0.00
Jupiter Neurosciences (JUNS) United States $0.019B 0.00
BioVie (BIVI) United States $0.019B 0.00
VYNE Therapeutics (VYNE) United States $0.019B 0.00
TherapeuticsMD (TXMD) United States $0.017B 0.00
ProPhase Labs (PRPH) United States $0.016B 0.00
GlycoMimetics (GLYC) United States $0.016B 0.00
Relmada Therapeutics (RLMD) United States $0.015B 0.00
Vivos Therapeutics (VVOS) United States $0.015B 0.00
Ernexa Therapeutics (ERNA) United States $0.014B 0.00
MEI Pharma (MEIP) United States $0.014B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.013B 0.00
Cosmos Health (COSM) United States $0.012B 0.00
Scienture Holdings (SCNX) United States $0.012B 0.00
BioLineRx (BLRX) Israel $0.011B 0.00
Minerva Neurosciences (NERV) United States $0.010B 1.83
Talphera (TLPH) United States $0.010B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.010B 0.00
Biomerica (BMRA) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Phio Pharmaceuticals (PHIO) United States $0.009B 0.00
Ainos (AIMD) United States $0.008B 0.00
Citius Pharmaceuticals (CTXR) United States $0.008B 0.00
Mangoceuticals (MGRX) United States $0.008B 0.00
Lyra Therapeutics (LYRA) United States $0.007B 0.00
Klotho Neurosciences (KLTO) United States $0.007B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
Indaptus Therapeutics (INDP) United States $0.007B 0.00
Plus Therapeutics (PSTV) United States $0.007B 0.00
Carisma Therapeutics (CARM) United States $0.007B 0.00
TransCode Therapeutics (RNAZ) United States $0.007B 0.00
Traws Pharma (TRAW) United States $0.007B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.006B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Aptorum Group (APM) United Kingdom $0.005B 0.00
Alaunos Therapeutics (TCRT) United States $0.005B 0.00
Incannex Healthcare (IXHL) Australia $0.005B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.004B 0.00
Conduit Pharmaceuticals (CDT) United States $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
Jaguar Animal Health (JAGX) United States $0.004B 0.00
PainReform (PRFX) Israel $0.004B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.004B 0.00
InMed Pharmaceuticals (INM) Canada $0.004B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
Redhill Biopharma (RDHL) Israel $0.003B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.001B 0.00
SHINECO (SISI) China $0.001B 0.00
China SXT Pharmaceuticals (SXTC) China $0.001B 0.00
Petros Pharmaceuticals (PTPI) United States $0.000B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
Aditxt (ADTX) United States $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00